TP53 and medulloblastoma: Because SP-141 can cross the blood–brain barrier fairly well [29] and can inhibit MDM2 in the presence or absence of wild-type p53 [29,31,32], the current study investigated the effects of SP-141 in brain tumor cell cultures and orthotopic xenograft models of medulloblastoma and glioblastoma.